167 related articles for article (PubMed ID: 16669931)
1. Levofloxacin in the treatment of ventilator-associated pneumonia.
Alvarez-Lerma F; Grau S; Alvarez-Beltrán M
Clin Microbiol Infect; 2006 May; 12 Suppl 3():81-92. PubMed ID: 16669931
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and pharmacodynamics of intravenous levofloxacin in patients with early-onset ventilator-associated pneumonia.
Pea F; Di Qual E; Cusenza A; Brollo L; Baldassarre M; Furlanut M
Clin Pharmacokinet; 2003; 42(6):589-98. PubMed ID: 12793843
[TBL] [Abstract][Full Text] [Related]
3. Gram-negative bacterial pneumonia: aetiology and management.
Koulenti D; Rello J
Curr Opin Pulm Med; 2006 May; 12(3):198-204. PubMed ID: 16582675
[TBL] [Abstract][Full Text] [Related]
4. Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: a prospective study.
Michalopoulos A; Fotakis D; Virtzili S; Vletsas C; Raftopoulou S; Mastora Z; Falagas ME
Respir Med; 2008 Mar; 102(3):407-12. PubMed ID: 18060758
[TBL] [Abstract][Full Text] [Related]
5. Levofloxacin for treatment of ventilator-associated pneumonia: a subgroup analysis from a randomized trial.
Shorr AF; Zadeikis N; Jackson WL; Ramage AS; Wu SC; Tennenberg AM; Kollef MH
Clin Infect Dis; 2005 Feb; 40 Suppl 2():S123-9. PubMed ID: 15712100
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of the combination of levofloxacin plus ceftazidime in the treatment of hospital-acquired pneumonia in the intensive care unit.
Bassetti M; Righi E; Rosso R; Mannelli S; Di Biagio A; Fasce R; Pallavicini FB; Marchetti F; Viscoli C
Int J Antimicrob Agents; 2006 Dec; 28(6):582-5. PubMed ID: 16979877
[TBL] [Abstract][Full Text] [Related]
7. [Ventilator-associated pneumonia and multiresistant bacteria].
Heininger A; Unertl K
Anasthesiol Intensivmed Notfallmed Schmerzther; 2007 Feb; 42(2):122-9. PubMed ID: 17309020
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and pharmacodynamics of levofloxacin in critically ill patients with ventilator-associated pneumonia.
Benko R; Matuz M; Doro P; Peto Z; Molnar A; Hajdu E; Nagy E; Gardi J; Soos G
Int J Antimicrob Agents; 2007 Aug; 30(2):162-8. PubMed ID: 17570646
[TBL] [Abstract][Full Text] [Related]
9. Combination therapy versus monotherapy: a randomised pilot study on the evolution of inflammatory parameters after ventilator associated pneumonia [ISRCTN31976779].
Damas P; Garweg C; Monchi M; Nys M; Canivet JL; Ledoux D; Preiser JC
Crit Care; 2006; 10(2):R52. PubMed ID: 16569261
[TBL] [Abstract][Full Text] [Related]
10. [Levofloxacin in the treatment of nosocomial infection in critically ill patients].
Alvarez Lerma F; Romero Luján JL; Morón Jiménez A; Ortiz López R; Borges Sá M; Grau Cerrato S; Gracia Arnillas MP;
Rev Esp Quimioter; 2008 Jun; 21(2):83-92. PubMed ID: 18509767
[TBL] [Abstract][Full Text] [Related]
11. Pneumonia due to Pseudomonas aeruginosa: the levofloxacin clinical trials experience.
Tennenberg AM; Davis NB; Wu SC; Kahn J
Curr Med Res Opin; 2006 May; 22(5):843-50. PubMed ID: 16709306
[TBL] [Abstract][Full Text] [Related]
12. Clinical applications of levofloxacin for severe infections.
Graninger W; Zeitlinger M
Chemotherapy; 2004; 50 Suppl 1():16-21. PubMed ID: 15319550
[TBL] [Abstract][Full Text] [Related]
13. Ventilator-associated pneumonia: what is new?
Chastre J
Surg Infect (Larchmt); 2006; 7 Suppl 2():S81-5. PubMed ID: 16895514
[TBL] [Abstract][Full Text] [Related]
14. Use of broad-spectrum antimicrobials for the treatment of pneumonia in seriously ill patients: maximizing clinical outcomes and minimizing selection of resistant organisms.
Niederman MS
Clin Infect Dis; 2006 Jan; 42 Suppl 2():S72-81. PubMed ID: 16355320
[TBL] [Abstract][Full Text] [Related]
15. Early predictors for infection recurrence and death in patients with ventilator-associated pneumonia.
Combes A; Luyt CE; Fagon JY; Wolff M; Trouillet JL; Chastre J
Crit Care Med; 2007 Jan; 35(1):146-54. PubMed ID: 17080004
[TBL] [Abstract][Full Text] [Related]
16. Therapy for ventilator-associated pneumonia: what works, what doesn't.
Hijazi M; Al-Ansari M
Respir Care Clin N Am; 2004 Sep; 10(3):341-58, vi. PubMed ID: 15458732
[TBL] [Abstract][Full Text] [Related]
17. Should antibiotic combinations be used to treat ventilator-associated pneumonia?
Eggimann P; Revelly JP
Semin Respir Crit Care Med; 2006 Feb; 27(1):68-81. PubMed ID: 16508883
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for relapse of ventilator-associated pneumonia in trauma patients.
Rangel EL; Butler KL; Johannigman JA; Tsuei BJ; Solomkin JS
J Trauma; 2009 Jul; 67(1):91-5; discussion 95-6. PubMed ID: 19590315
[TBL] [Abstract][Full Text] [Related]
19. Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients?
Eachempati SR; Hydo LJ; Shou J; Barie PS
J Trauma; 2009 May; 66(5):1343-8. PubMed ID: 19430237
[TBL] [Abstract][Full Text] [Related]
20. Reduction in inadequate empiric antibiotic therapy for ventilator-associated pneumonia: impact of a unit-specific treatment pathway.
Magnotti LJ; Schroeppel TJ; Fabian TC; Clement LP; Swanson JM; Fischer PE; Bee TK; Maish GO; Minard G; Zarzaur BL; Croce MA
Am Surg; 2008 Jun; 74(6):516-22; discussion 522-3. PubMed ID: 18556994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
